RUSSO, Mariangela
 Distribuzione geografica
Continente #
NA - Nord America 2.626
EU - Europa 2.252
AS - Asia 1.493
OC - Oceania 49
AF - Africa 19
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.462
Nazione #
US - Stati Uniti d'America 2.559
IT - Italia 937
CN - Cina 927
GB - Regno Unito 212
FR - Francia 202
DE - Germania 187
JP - Giappone 169
IE - Irlanda 112
SE - Svezia 76
HK - Hong Kong 75
ES - Italia 74
DK - Danimarca 72
FI - Finlandia 72
IN - India 70
SG - Singapore 70
CA - Canada 56
UA - Ucraina 46
BE - Belgio 39
KR - Corea 39
PL - Polonia 39
NL - Olanda 38
AU - Australia 31
IL - Israele 29
TW - Taiwan 29
AT - Austria 27
CH - Svizzera 25
VN - Vietnam 25
NZ - Nuova Zelanda 18
CZ - Repubblica Ceca 17
HU - Ungheria 14
GR - Grecia 11
MX - Messico 11
TR - Turchia 11
PT - Portogallo 10
TH - Thailandia 9
AM - Armenia 8
RO - Romania 8
RU - Federazione Russa 8
BR - Brasile 7
IR - Iran 7
NO - Norvegia 7
HR - Croazia 6
SN - Senegal 6
AR - Argentina 5
AE - Emirati Arabi Uniti 4
MA - Marocco 4
ZA - Sudafrica 4
BG - Bulgaria 3
CO - Colombia 3
CY - Cipro 3
KZ - Kazakistan 3
MY - Malesia 3
SA - Arabia Saudita 3
AP - ???statistics.table.value.countryCode.AP??? 2
BY - Bielorussia 2
DZ - Algeria 2
ID - Indonesia 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
NG - Nigeria 2
PE - Perù 2
UZ - Uzbekistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.462
Città #
Ann Arbor 523
Chandler 204
Beijing 175
Shanghai 123
Torino 113
Redwood City 110
Guangzhou 102
Houston 101
Fairfield 100
Dublin 99
Milan 88
Turin 84
Ashburn 76
Dearborn 66
Cambridge 61
Woodbridge 61
Tokyo 50
New York 49
Seattle 49
Wilmington 47
Lappeenranta 36
Singapore 35
Hangzhou 32
Nanjing 32
Wuhan 32
Boston 31
Brussels 29
Rome 29
London 28
Villeurbanne 28
Medford 27
Pisa 27
San Diego 27
Paris 26
Nyköping 25
Boardman 24
Genoa 24
Carrara 23
Los Angeles 21
Princeton 21
Vienna 21
Barcelona 20
Berlin 20
Fremont 20
Warsaw 20
Dong Ket 18
Jacksonville 18
Munich 18
Chongqing 16
Duncan 16
Taipei 16
Toulouse 16
Buffalo 15
Central 15
Jinan 15
Chicago 14
San Francisco 14
Central District 12
Bologna 11
Luni 11
Phoenix 11
Tianjin 11
Toronto 11
Bengaluru 10
Changsha 10
Mountain View 10
Ottawa 10
Pittsburgh 10
Rehovot 10
Shenzhen 10
Zhengzhou 10
Amsterdam 9
Chengdu 9
Dunedin 9
Hong Kong 9
Lyngby 9
Menlo Park 9
Simi Valley 9
Washington 9
Birmingham 8
Budapest 8
Heidelberg 8
Helsinki 8
Napoli 8
San Mateo 8
Trieste 8
Yerevan 8
Baltimore 7
Carlow 7
Cincinnati 7
Melbourne 7
Nanchang 7
Naples 7
Portland 7
Rochester 7
Serio 7
Silver Spring 7
Bangkok 6
Brno 6
Chennai 6
Totale 3.501
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.760
Adaptive mutability of colorectal cancers in response to targeted therapies 1.691
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets 483
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer 474
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 427
Mixed lineage kinase MLK4 is activated in colorectal cancers where it synergistically cooperates with activated RAS signaling in driving tumorigenesis 221
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin 193
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer 181
RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells. 155
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer 144
A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility 134
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies 124
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. 109
Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies 97
Climbing RAS, the Everest of Oncogenes. 94
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 92
Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer 75
Adaptive Evolution: How Bacteria and Cancer Cells Survive Stressful Conditions and Drug Treatment 65
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells 37
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity 20
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 9
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells 8
Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 5
Abstract 5900: Tolerance to colibactin correlates with response to chemotherapeutic agents in colorectal cancer 5
Abstract C94: Heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer are sensitive to concomitant inhibition of EGFR and MEK 4
Abstract A120: Adaptive mutability of colorectal cancers in response to targeted therapies 4
Abstract B110: Heterogeneous genetic alterations emerge during acquired resistance to anti-EGFR therapy in colorectal cancer 3
Abstract 3588: Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 2
Totale 6.616
Categoria #
all - tutte 12.758
article - articoli 0
book - libri 0
conference - conferenze 188
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.946


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020621 0 18 28 58 41 64 52 56 88 84 84 48
2020/20211.202 44 68 83 123 108 92 133 87 97 107 109 151
2021/20221.502 172 141 141 190 77 88 118 109 114 86 142 124
2022/20231.252 98 103 103 113 87 155 85 114 114 63 105 112
2023/20241.323 107 111 115 98 96 89 131 116 44 147 127 142
2024/202581 81 0 0 0 0 0 0 0 0 0 0 0
Totale 6.616